Literature DB >> 26054727

A novel protein-based subunit Shigella vaccine candidate.

Malabi M Venkatesan1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26054727     DOI： 10.1038/icb.2015.56

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN： 0818-9641            Impact factor:   5.126


× No keyword cloud information.
  10 in total

Review 1.  Inactivated and subunit vaccines to prevent shigellosis.

Authors:  Robert W Kaminski; Edwin V Oaks
Journal:  Expert Rev Vaccines       Date:  2009-12       Impact factor: 5.217

Review 2.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

3.  An update on vaccines against Shigella.

Authors:  Shai Ashkenazi; Dani Cohen
Journal:  Ther Adv Vaccines       Date:  2013-09

4.  Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine.

Authors:  Mark S Riddle; Robert W Kaminski; Carlos Williams; Chad Porter; Shahida Baqar; Alexis Kordis; Theron Gilliland; Joyce Lapa; Melissa Coughlin; Chris Soltis; Erica Jones; Jackie Saunders; Paul B Keiser; Ryan T Ranallo; Robert Gormley; Michael Nelson; K Ross Turbyfill; David Tribble; Edwin V Oaks
Journal:  Vaccine       Date:  2011-07-23       Impact factor: 3.641

5.  Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children.

Authors:  Justen H Passwell; Shai Ashkenazi; Yonit Banet-Levi; Reut Ramon-Saraf; Nahid Farzam; Liat Lerner-Geva; Hadas Even-Nir; Baruch Yerushalmi; Chiayung Chu; Joseph Shiloach; John B Robbins; Rachel Schneerson
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

6.  Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.

Authors:  Karen L Kotloff; James P Nataro; William C Blackwelder; Dilruba Nasrin; Tamer H Farag; Sandra Panchalingam; Yukun Wu; Samba O Sow; Dipika Sur; Robert F Breiman; Abu Sg Faruque; Anita Km Zaidi; Debasish Saha; Pedro L Alonso; Boubou Tamboura; Doh Sanogo; Uma Onwuchekwa; Byomkesh Manna; Thandavarayan Ramamurthy; Suman Kanungo; John B Ochieng; Richard Omore; Joseph O Oundo; Anowar Hossain; Sumon K Das; Shahnawaz Ahmed; Shahida Qureshi; Farheen Quadri; Richard A Adegbola; Martin Antonio; M Jahangir Hossain; Adebayo Akinsola; Inacio Mandomando; Tacilta Nhampossa; Sozinho Acácio; Kousick Biswas; Ciara E O'Reilly; Eric D Mintz; Lynette Y Berkeley; Khitam Muhsen; Halvor Sommerfelt; Roy M Robins-Browne; Myron M Levine
Journal:  Lancet       Date:  2013-05-14       Impact factor: 79.321

7.  Characterization of a novel fusion protein from IpaB and IpaD of Shigella spp. and its potential as a pan-Shigella vaccine.

Authors:  Francisco J Martinez-Becerra; Xiaotong Chen; Nicholas E Dickenson; Shyamal P Choudhari; Kelly Harrison; John D Clements; William D Picking; Lillian L Van De Verg; Richard I Walker; Wendy L Picking
Journal:  Infect Immun       Date:  2013-09-23       Impact factor: 3.441

8.  Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.

Authors:  Shannon J Heine; Jovita Diaz-McNair; Abhay U Andar; Cinthia B Drachenberg; Lillian van de Verg; Richard Walker; Wendy L Picking; Marcela F Pasetti
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

9.  Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.

Authors:  Shannon J Heine; Olga L Franco-Mahecha; Xiaotong Chen; Shyamal Choudhari; William C Blackwelder; Maarten L van Roosmalen; Kees Leenhouts; Wendy L Picking; Marcela F Pasetti
Journal:  Immunol Cell Biol       Date:  2015-03-17       Impact factor: 5.126

10.  Bacterium-like particles for efficient immune stimulation of existing vaccines and new subunit vaccines in mucosal applications.

Authors:  Natalija Van Braeckel-Budimir; Bert Jan Haijema; Kees Leenhouts
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.